2022 年 81 巻 3 号 p. 127-132
Surgical treatment for metastatic liver cancer from colorectal cancer has reached a positive consensus owing toeffective new chemotherapies and improvements in surgical techniques. There is currently some evidence available about surgical treatments for metastatic liver cancer from various organs, and it is the beginning of a new erafor radical treatment for noncolorectal cancer. Clinically, the treatment strategy for metastatic cancer is graduallychanging for each organ. Therefore, it is true that some categories of patients can reach longer survival than before.However, the number included in each study is very small, and robust evidence has not been obtained. Therefore,the indication for metastatic liver cancer from noncolorectal cancer remains controversial. The aim of this reviewarticle is to show the current treatment strategies for metastatic liver cancer from various organs, focusing on livermetastasis from colorectal cancer.